In the News
April 26, 2023
Cameron Kim wins Klein Family Distinguished Teaching Award
Klein Family Distinguished Teaching Award Cameron Kim, PhD Recognizes an outstanding educator. These faculty inspire students to learn and apply knowledge, engage students in the classroom and share their love of engineering. Cameron is passionate about training the next [...]
April 25, 2023
Cameron Kim Wins Bass Connections Leadership Award

March 30, 2023 | Duke School of Medicine
Collaboration Seeks Genetic Clues to Chronic Lung Disease
Idiopathic pulmonary fibrosis (IPF) is a disease that causes scarring on the lungs. Over time, as more scarring occurs, patients experience decreased lung function and difficulty breathing. Once diagnosed, most patients die within five years.

March 30, 2023 | Duke School of Medicine
Study Reveals How UV Radiation May Drive Melanoma
Raluca Gordân, PhD, and team investigated how transcription factors may affect the production of genetic mutations, or mutagenesis, by binding to the wrong sites after being exposed to ultraviolet (UV) radiation.

March 27, 2023 | Duke Today
Alumnus Ariel Kantor Cited by Forbes Europe in 30 Under 30 List
Duke alumnus, former member of the Gersbach lab, and Rhodes Scholar Ariel Kantor was selected for Forbes Europe's latest "30 under 30" — an annual listing of top young innovators, entrepreneurs and world changers.

February 1, 2023 | Duke OTC
Asokan named Global Scholar

December 15, 2022 | Duke Today
Gersbach Elected to National Academy of Inventors

December 13, 2022 | Duke Today
Gene Therapy for Heart Attacks in Mice Just Got More Precise
A team of Duke scientists studying how other animals regrow damaged tissues has made an important step toward controlling at least one part of the regenerative machinery with that kind of precision.

November 30, 2022 | Duke School of Medicine
Aravind Asokan to Lead Partnership with Danaher Corporation to Accelerate Gene Therapy Breakthroughs
Aravind Asokan will lead a new strategic partnership with Danaher Corporation to form the first Danaher Beacon for Gene Therapy Innovation, a new initiative designed to access breakthrough science to create technologies and applications that will improve human health.

November 16, 2022 | Duke Research Blog
Gersbach Among Most Cited Scientists
Gersbach is one of 30 Duke faculty to make this year's list

November 11, 2022 | Cision PR Newswire
Danaher Launches Beacon Initiative and Its First Partnership Focused on Gene Therapy Innovation
Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced that it has entered a strategic partnership with Duke University to form its first Danaher Beacon for Gene Therapy Innovation.

October 13, 2022 | WRAL TechWire
Kris Wood startup Tavros Therapeutics strikes $430M deal with Bayer subsidiary
The oncology startup Tavros Therapeutics has signed a five-year collaboration with Vividion Therapeutics that could bring as much as $430.5 million to the RTP firm.

October 5, 2022 | Duke Today
New RNA-based Tool Can Illuminate Brain Circuits, Edit Specific Cells
Editing technology is precise and broadly applicable to all tissues and animal species

October 4, 2022 | Duke CTSI
Duke Kannapolis Director Outlines Future at North Carolina Research Campus
Svati H. Shah, MD, MHS, spoke to partners at the North Carolina Research Campus (NCRC) about the pivotal role of Duke Kannapolis at the 350-acre translational science hub focused on human health and nutrition.

September 6, 2022
Anoop Patel joins Duke, CAGT
We are excited to welcome Anoop Patel, MD, associate professor of neurosurgery, to the CAGT community. Patel graduated magna cum laude from Harvard Medical School and completed residency as well as a research fellowship at Massachusetts General Hospital. He comes to Duke [...]

July 20, 2022 | Duke School of Medicine
Tata to Receive International Society for Regenerative Biology Rising Star Award

July 1, 2022
Pranam Chatterjee Joins Duke, CAGT
We are excited to welcome Pranam Chatterjee, PhD, assistant professor of biomedical engineering, to the CAGT community. Chatterjee's research focus explores how to develop cells and tissues that can improve reproductive longevity and fertility. “The work that I do is very [...]

June 6, 2022
Locking Leukemia’s Cellular Escape Hatch
By Alissa Kocer Leukemia starts in cells that would normally develop into different types of blood cells. About 61,000 people in the U.S. are diagnosed each year, and depending on the type of leukemia and the age of the patient, five-year survival rates vary between about [...]

April 28, 2022 | Gilbert Family Foundation
Gersbach awarded $1.2M Gilbert Family Foundation grant for Gene Therapy Initiative
The Gilbert Family Foundation, announced more than $18 million in grants to fund a new three-year campaign as part of the organization’s Gene Therapy Initiative.

April 20, 2022 | Emory News Center
Duke, Emory collaboration successfully uses mRNA to activate genes
What if we could regulate the way genes are expressed? That question has long intrigued researchers, and a new collaboration between Duke and Emory University helps narrow the knowledge gap by showing for the first time that mRNA can be used to activate genes in animals.

March 31, 2022 | Duke Health News
Cancer Repair Mechanism Could Be Potential Drug Target
Disrupting a key cell repair mechanism could extend the benefit of targeted therapies

March 10, 2022
Dedicated to Mentoring
At Duke, mentoring isn't just about trainees' scientific development. Our faculty care about our trainees' growth as individuals too.

February 11, 2022
CAGT names first Genome Technology Fellows
The Center for Advanced Genomic Technologies (CAGT) provided fellowships to support postdoctoral trainees who are conducting research to develop and apply genomic technologies and methods for associated computational analyses to basic and applied biomedical sciences. We [...]

February 11, 2022 | Duke Precision Genomics Collaboratory